![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr2.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
![Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00296-8/MediaObjects/41523_2021_296_Fig1_HTML.png)
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer
![Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-26/jco.19.00647/20190827/images/large/jco.19.00647ta1.jpeg)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub](https://www.pdffiller.com/preview/428/167/428167845/large.png)
The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub
![Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2022/op.2022.18.issue-3/op.21.00482/20220303/images/large/op.21.00482t1.jpeg)
Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/86436036/mini_magick20220524-18718-tg1b1v.png?1653457246)
PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu
![Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda](https://integrativeoncology-essentials.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-28-at-11.39.28-AM-519x1024.png)
Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda
![Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822002161-fx1.jpg)
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect
![Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-09710-8/MediaObjects/10434_2021_9710_Fig1_HTML.png)
Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink
![Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid | BMC Health Services Research | Full Text Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid | BMC Health Services Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12913-019-3988-2/MediaObjects/12913_2019_3988_Fig1_HTML.png)